SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Your weed is 5 minutes out

    By

    On the heels of the company’s February announcement that they intend to acquire alcohol delivery app Drizly, Uber’s CEO Dara Khosrowshahi says cannabis delivery could be on the roadmap in the near future.

    “When the road is clear for cannabis, when federal laws come into play, we’re absolutely going to take a look at it,” Dara Khosrowshahi told CNBC.



    No, not Drizzy — Drizly

    With new federal legislation in the works, there appears to be an opportunity to dominate delivery by simply extending Uber’s existing infrastructure. This is especially true with the help of Drizly’s proprietary ID-scanning technology, which drivers use at the door.

    But… cannabis isn’t booze

    Companies like Dutchie are already working with retailers on both sides of the border to deliver cannabis, and they’d likely say that there are specific challenges to cannabis that Uber isn’t familiar with. Retailers aren’t always equipped to maintain fast-moving inventories, for example. 

    It’s also tough to predict whether federal legislation would regulate delivery or if distribution would fall to state jurisdictions and what that would look like. A patchwork of regulations could make it difficult to pivot and scale. 

    What’s next

    For now, Uber’s CEO says there are a lot of existing, legal delivery opportunities to mine, such as groceries and booze.

    “We see so much opportunity out there,” he said, “and we’re going to focus on the opportunity at hand.”


    BofC

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free